Skip to Content

G 341 (Oxybutynin Chloride Extended Release 5 mg)

Pill with imprint G 341 is Purple, Round and has been identified as Oxybutynin Chloride Extended Release 5 mg. It is supplied by Teva Pharmaceuticals USA.

Oxybutynin is used in the treatment of urinary incontinence; urinary frequency; dysuria; neurogenic detrusor overactivity and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 341

Oxybutynin chloride extended release 5 mg G 341
Oxybutynin chloride extended release 5 mg G 341
Oxybutynin chloride extended release 5 mg G 341

Oxybutynin Chloride Extended Release

Imprint
G 341
Strength
5 mg
Color
Purple
Size
7.00 mm
Shape
Round
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-5206
Inactive Ingredients
hypromelloses, lactose monohydrate, methacrylic acid, microcrystalline cellulose, magnesium silicate, triethyl citrate, FD&C Blue No. 2, FD&C Red No. 40

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "G 341"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.